A deadly flu season is gripping Iran, claiming lives and leaving millions struggling to access vital vaccines. This year, the H3N2 influenza strain has swept across the country, and the consequences are devastating. But what's really happening? Let's dive in.
Shadi, a concerned mother from Tehran, managed to scrape together a small fortune, about $15, to vaccinate her children. But for herself and her husband, the money simply wasn't there. "We'll just have to hope we don’t get sick," she said, a sentiment echoed by many across the nation.
Reports from Iranian media indicate that at least 101 people have tragically died from pneumonia linked to the flu strain. Health officials are warning that the worst is yet to come, with winter still looming. The situation has exposed a series of policy failures, including the government's removal of free vaccine allocations for vulnerable groups, a domestic vaccine program without international approval, and a healthcare system struggling to meet demand as prices skyrocket.
"The optimal time for injection was mainly at the beginning of the season," according to Mohammad Hashemi, a spokesperson for Iran’s Food and Drug Organization. However, for many Iranians, the opportunity to get vaccinated vanished before vaccines even reached pharmacy shelves.
Hanieh, who used to get free flu vaccines for her elderly parents from a government pharmacy, was met with disappointment this year. The pharmacist told her, "You came late and it’s all gone. You have to buy from the private sector." This is because the Ministry of Health and the Food and Drug Organization made an unprecedented decision this year: they allocated no vaccine quotas for sensitive and vulnerable populations. This policy shift has created a two-tiered system where access to vaccines depends on the ability to pay.
Roya, a pharmacy owner, requested vaccines in September, as she does every year. She received only eight doses for her busy pharmacy, a stark contrast to previous years when her own family members could easily get vaccinated.
Three types of vaccines were available in Iranian pharmacies from late September to mid-November: a domestically produced version and two imported varieties from France and the Netherlands. But even those willing to pay found empty shelves by November. A 24-hour government pharmacy in Ahvaz confirmed that they ran out of stock by mid-November.
The shortages forced difficult choices. Sara, a resident of Rey, found only one dose of an Iranian-made vaccine for her teenage daughter, while her father was hospitalized with influenza and pneumonia. Raheleh, a breast cancer patient, managed to secure a Dutch vaccine through a connection at a private hospital, recognizing the critical need before beginning chemotherapy.
But here's where it gets controversial... Even those who got vaccinated aren't necessarily protected. Reza, who got his first flu shot this fall, contracted influenza. He suspects the Iranian vaccine was ineffective, drawing comparisons to the country's COVID vaccines. The Ministry of Health says the Iranian vaccine, Fluguard, is not suitable for people under 18, and it has not been approved by major international health authorities.
Medical experts highlight that flu vaccines are based on previous years' dominant strains. "Vaccines produced before this strain may not necessarily overcome this new type," said Rouzbeh Esfandiari, a former emergency room physician. Official statements initially emphasized that most deaths happened among elderly patients and those with underlying conditions. Then came the case of a 26-year-old man who died within 24 hours of developing symptoms. "The virus is in a severe circulation phase and can also create a super-acute aggressive pattern in non-high-risk groups,” said the head of Hormozgan University of Medical Sciences.
Esfandiari points to air quality as another critical factor. Iranian cities are among the world’s most polluted, weakening the respiratory system and making people more susceptible to the flu. Some patients then contract COVID-19 or develop bacterial pneumonia.
And this is the part most people miss... Hossein Kermanpour, from the Health Ministry, noted that most fatalities involved unvaccinated individuals. However, with vaccines unaffordable or unavailable, this offers little comfort.
What do you think? Do you believe the government's response has been adequate? Share your thoughts in the comments below.
